Coronavirus: Sanofi CEO explains its multi-pronged effort to treat and test for COVID-19

Covid-19 Drug Tests: We Have to Be Realistic, Sanofi SaysПодробнее

Sanofi CEO on coronavirus vaccine development and the pressure 'to get it right'Подробнее

Coronavirus: Sanofi CEO on testing vaccine, existing drugs to combat pandemicПодробнее

Sanofi CEO Paul Hudson on cancer research, Covid-19 vaccine and moreПодробнее

Sanofi Pasteur, industry collaborate on COVID-19Подробнее

Sanofi CEO Paul Hudson on the coronavirus, the FDA, drug development and moreПодробнее

Sanofi CEO on two-pronged approach to developing Covid-19 vaccineПодробнее

U.S. Likely to Get Sanofi's Covid-19 Vaccine First If It SucceedsПодробнее

Coronavirus: GlaxoKlineSmith CEO talks 'unprecedented collaboration' with Sanofi on vaccineПодробнее

GSK & Sanofi partnering to develop coronavirus vaccineПодробнее

Coronavirus: Sanofi CEO on fast-tracking vaccine development processПодробнее

Novavax signs $1.2 billion vaccine deal with Sanofi #shortsПодробнее

GSK and Sanofi joining forces to develop a vaccine for COVID-19Подробнее

Sanofi CEO Paul Hudson on COVID-19 and potential vaccine (Full Stream 11/10)Подробнее

Coronavirus vaccine will be developed in a year or so: Sanofi head of researchПодробнее

Covid-19: Sanofi backpedals on US vaccine priority after French outrageПодробнее

Glaxo Joins Forces With Sanofi to Develop Coronavirus VaccineПодробнее

Sanofi CEO on breakthroughs in cancer research, COVID-19 vaccine development, and drug pricingПодробнее

600 million COVID-19 Vaccine Doses to be produced by SanofiПодробнее